Development and Scale Up Validation of Small Molecule Viral Sensitizers for Increased Vaccine Manufacturing Yields

Virica’s Viral Sensitizer technology (VSE™) enhances vaccine manufacturing yields by temporarily reducing innate cellular responses that typically limit viral production. Our collaboration data shows VSE™ significantly increase viral yields across multiple scales and production formats, achieving up to 12.5x increase depending on application. This approach addresses critical vaccine shortages and manufacturing bottlenecks, improving vaccine availability and productivity. Virica offers comprehensive support, including analytical services and regulatory assistance, to optimize vaccine production processes.